These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2318551)
61. Monitoring compliance through analysis of drug and metabolite levels. Mollica JA Control Clin Trials; 1984 Dec; 5(4 Suppl):505-14. PubMed ID: 6518778 [TBL] [Abstract][Full Text] [Related]
62. Comments on "Embryo-fetal development studies with the dietary supplement vinpocetine in the rat and rabbit" (Catlin et al. Birth Defects Research. 2018, 110, 883-896). Wise LD Birth Defects Res; 2018 Nov; 110(18):1372-1373. PubMed ID: 30362293 [No Abstract] [Full Text] [Related]
67. Influence of vinpocetine on warfarin-induced inhibition of coagulation. Hitzenberger G; Sommer W; Grandt R Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):323-8. PubMed ID: 2272713 [TBL] [Abstract][Full Text] [Related]
68. Investigation of the possible influence of the absorption of vinpocetine with concomitant application of magnesium-aluminium-hydroxide gel. Lohmann A; Grobara P; Dingler E Arzneimittelforschung; 1991 Nov; 41(11):1164-7. PubMed ID: 1810262 [TBL] [Abstract][Full Text] [Related]
69. Glibenclamide steady state plasma levels during concomitant vinpocetine administration in type II diabetic patients. Grandt R; Braun W; Schulz HU; Lührmann B; Frercks HJ Arzneimittelforschung; 1989 Nov; 39(11):1451-4. PubMed ID: 2515864 [TBL] [Abstract][Full Text] [Related]
70. The influence of the route of administration of imipramine on imipramine and desipramine blood levels. Rigal J; Albin H; Fança X; Demotes-Mainard F; Vinçon G J Clin Psychopharmacol; 1989 Oct; 9(5):364-7. PubMed ID: 2677063 [TBL] [Abstract][Full Text] [Related]
71. Vinpocetine therapy does not change imipramine pharmacokinetics in man. Hitzenberger G; Schmid R; Braun W; Grandt R Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):99-104. PubMed ID: 2318551 [TBL] [Abstract][Full Text] [Related]